- Home
- MRNA vs WYNN Comparison
MRNA vs WYNN Comparison
Compare MRNA & WYNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- WYNN
- Stock Information
- Founded
- MRNA 2010
- WYNN 2002
- Country
- MRNA United States
- WYNN United States
- Employees
- MRNA N/A
- WYNN N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- WYNN Hotels/Resorts
- Sector
- MRNA Health Care
- WYNN Consumer Discretionary
- Exchange
- MRNA Nasdaq
- WYNN Nasdaq
- Market Cap
- MRNA 10.6B
- WYNN 8.5B
- IPO Year
- MRNA 2018
- WYNN 2002
- Fundamental
- Price
- MRNA $24.25
- WYNN $87.93
- Analyst Decision
- MRNA Hold
- WYNN Strong Buy
- Analyst Count
- MRNA 20
- WYNN 12
- Target Price
- MRNA $51.94
- WYNN $115.50
- AVG Volume (30 Days)
- MRNA 8.5M
- WYNN 2.3M
- Earning Date
- MRNA 05-01-2025
- WYNN 05-06-2025
- Dividend Yield
- MRNA N/A
- WYNN 1.14%
- EPS Growth
- MRNA N/A
- WYNN N/A
- EPS
- MRNA N/A
- WYNN 3.75
- Revenue
- MRNA $3,177,000,000.00
- WYNN $6,965,449,000.00
- Revenue This Year
- MRNA N/A
- WYNN $1.61
- Revenue Next Year
- MRNA $11.16
- WYNN $2.66
- P/E Ratio
- MRNA N/A
- WYNN $23.45
- Revenue Growth
- MRNA N/A
- WYNN N/A
- 52 Week Low
- MRNA $23.15
- WYNN $65.25
- 52 Week High
- MRNA $170.47
- WYNN $107.81
- Technical
- Relative Strength Index (RSI)
- MRNA 38.02
- WYNN 67.52
- Support Level
- MRNA $23.70
- WYNN $78.78
- Resistance Level
- MRNA $28.52
- WYNN $84.83
- Average True Range (ATR)
- MRNA 1.36
- WYNN 2.45
- MACD
- MRNA -0.09
- WYNN 1.14
- Stochastic Oscillator
- MRNA 11.11
- WYNN 97.69
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About WYNN Wynn Resorts Limited Common stock
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.